• Form CRS (PDF)
  • Client Log In
  • Mutual Fund Log In
Trillium Asset Management Trillium Asset Management
  • Shareholder Proposals
  • Proxy Voting
  • Views & Updates
  • Contact
  • Back to TrilliumInvest.com

What’s On Your Plate? Pressing Chipotle on Pesticides

February 25, 2010

Susan Baker Trillium Asset Management Corporation (“Trillium”) has been pressing restaurant chains to reduce the use of pesticides in their supply chains, continuing our research and advocacy on sustainable food and agriculture.1 Reducing pesticides is a logical step toward protecting the health of farm workers and consumers and minimizing soil and water contamination. The introduction of GMO seed has actually resulted an increase in pesticide use. Yet the restaurant industry has by and large failed to exercise its influence for good in this area. We think it is important for restaurants to get active to reduce pesticide use for a …

Read More

Chipotle – Ban on Pesticide Use (2010)

February 4, 2010

WHEREAS Chipotle has stated that “ ’Food With Integrity’ isn’t a marketing slogan. . . . It’s a philosophy that we can always do better in terms of the food we buy.”   Yet, Chipotle has not systematically addressed the use of pesticides in its food sources. (http://www.chipotle.com/html/fwi.aspx) Chipotle customers and shareholders have come to expect the company to provide leadership in product sustainability. The company has begun gathering important information on water treatment and pesticide management from its avocado suppliers, but Chipotle does not report on this information to the public.  Reporting on such practices as those used in its …

Read More

Dow Chemicals – Report on Pesticde Use and Asthma (2008)

January 23, 2008

WHEREAS: Approximately half of Dow’s end-use pesticide products (73 of 149) may be linked to asthma and other respiratory problems through active or inert ingredients or metabolites. Common Dow pesticide products with ingredients linked to respiratory problems include: FulTime, Dursban, Lorsban, Glyphomax, Tordon, Telone, Starane, Dithane, Widematch, Vikane/Profume and more. According to the Centers for Disease Control and Prevention (CDC), 16 million people in the U.S. suffer from asthma. Since the mid-1980s, asthma rates have reached epidemic levels. CDC states that nearly 1 in 8 school-aged children have asthma, the leading cause of school absenteeism due to chronic illness. Children …

Read More

Recent Posts

  • Trillium Responds to SEC’s Request for Input on Climate Change and ESG
  • Newsletter: June 2021 – With the Shame of Austerity Exposed, We Can Embrace Resilience
  • Newsletter: June 2021 – Trillium’s 2021 Investment Team Racial Equity Project: Overview and Outcomes
  • Newsletter: June 2021 – Strong Support for Trillium’s Racial Justice and Good Governance
  • Newsletter: June 2021 – Leading Retailers Support Workers on the Front Lines During the Pandemic

Recent Comments

    BCorp_logo_transparent
    loggo
    PRI-Sig-Web-V1
    60c786462eca4767cdb5f850_5ed50aabb6d6d8168afd5fc2_ussif_memberlogo_2017_72dpi
    62067026a1b3b6333377da54_American Sustainable Business Network Logo
    60df13624c0183ae5d74f1c4_Eurosif_Blue
    60df13624c01830e4674f1c3_VBDO_Blue
    60df13624c01836f6b74f1c5_UKSIF_blue
    Amsterdam
    Boston
    Edinburgh
    London
    Melbourne
    San Francisco
    Sydney
    Boston

    Two Financial Center
    60 South Street, Suite 1100
    Boston, MA 02111
    ‍
    (800) 548-5684
    (617) 423-6655

    trillium-primary-logo
    Active Portfolios, Global Impact: Putting Assets into Action since 1982®
    By clicking the links to third party sites you are leaving the Trillium site and entering a third party site. Trillium are not responsible for any information contained on the third party site.
    © 2023 Trillium Asset Management. All Rights Reserved. Trillium Asset Management is a registered trademark.
    Privacy & Use Policies
    Green InvestingTM

    Hit enter to search or ESC to close

    Logo
    • Shareholder Proposals
    • Proxy Voting
    • Views & Updates
    • Contact
    • Back to TrilliumInvest.com